Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents.
Andrew R ZulloSadia SharminYoojin LeeLori A DaielloNishant R ShahW John BoscardinDavid D DoreSei J LeeMichael A SteinmanPublished in: Journal of the American Geriatrics Society (2017)
More than one-third of older NH residents in the United States do not have any secondary prevention medications initiated after AMI, with fewer medications initiated in older residents; women; and those with, DNR orders, poor physical function, and cognitive impairment. A lack of evidence about the safety and effectiveness of secondary preventions medications in the NH population and unmeasured person-centered goals of care are plausible explanations for these findings.
Keyphrases
- cognitive impairment
- healthcare
- randomized controlled trial
- physical activity
- middle aged
- community dwelling
- room temperature
- acute myocardial infarction
- systematic review
- palliative care
- polycystic ovary syndrome
- public health
- pregnant women
- chronic pain
- pain management
- insulin resistance
- percutaneous coronary intervention
- affordable care act